COMPASS Pathways plc（以下简称COMPASS）近日宣布与Radial建立战略合作伙伴关系，旨在通过创新技术优化患者体验，并为COMP360（其研发的裸盖菇素疗法）的未来给药模式提供重要参考依据。此次合作将聚焦于开发数字化工具与支持平台，提升患者在接受精神健康治疗过程中的参与度与便利性。COMP360目前正处于临床研究阶段，用于治疗难治性抑郁症等精神类疾病。双方将通过数据整合与分析，探索更个性化、可扩展的医疗服务方案，为精神健康领域的治疗模式创新注入新动力。
COMPASS Pathways plc（以下简称COMPASS）近日宣布与Radial建立战略合作伙伴关系，旨在通过创新技术优化患者体验，并为COMP360（其研发的裸盖菇素疗法）的未来给药模式提供重要参考依据。此次合作将聚焦于开发数字化工具与支持平台，提升患者在接受精神健康治疗过程中的参与度与便利性。COMP360目前正处于临床研究阶段，用于治疗难治性抑郁症等精神类疾病。双方将通过数据整合与分析，探索更个性化、可扩展的医疗服务方案，为精神健康领域的治疗模式创新注入新动力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.